Kirkland Advises Warburg Pincus on Acquisition of Pharma Intelligence

Kirkland & Ellis is advising Warburg Pincus, a leading global growth investor, on the acquisition of Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa PLC (LSE:INF.L), the international B2B markets knowledge services and business intelligence group. Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment.

Read the Warburg Pincus press release

The Kirkland team was led by corporate partners Adrian Maguire, Dan Clarke, Keir MacLennan and Keri Schick Norton; debt finance partners Eric Wedel, Neel Sachdev, Ben Steadman and Stefan Arnold-Soulby; tax partners Peter Abbott and Sam Trowbridge; antitrust partners Paula Riedel and Matthew Sinclair-Thomson; and technology and IP transactions partner Jenny Wilson.